Wednesday's Stock Spotlight: Qualcomm (QCOM), ServiceTitan, and Lithium Americas Drive Trading Action

Qualcomm (QCOM) shares fell 1.34% to $182.40 on Monday after announcing a multiyear patent cross-license with Huawei, covering 5G, AI, and networking. The deal's financial impact is unclear. Huawei's total patent agreements are expected to exceed $6.9 billion, but this figure includes multiple deals. Qualcomm's shares are 4.08% above the GF Value estimate of $175.25.

Qualcomm and Huawei signed a multi-year patent cross-licensing deal covering 5G, AI, and other technologies. For the first time in 25 years, Qualcomm will pay Huawei, highlighting Huawei's expanded patent portfolio. The deal includes Qualcomm's purchase of specific Huawei US patents, subject to regulatory approval. Huawei's total patent licensing value will exceed $6.9 billion. The specific value of the Qualcomm deal was not disclosed but exceeds $133.9 million.

Qualcomm is suing ARM, seeking to stop royalty payments for five years, claiming ARM withheld chip-testing tools and leaked sensitive information. ARM denies wrongdoing. The case could impact Android phones, as Qualcomm's Snapdragon chips rely on ARM's technology. Judge Maryellen Noreika is reviewing the case.

Huawei announced a multi-year patent licensing deal with Qualcomm, where Qualcomm will pay for Huawei's patents for the first time. The agreement covers 5G, compute, AI, and networking. Terms were not disclosed, and regulatory approval is pending. Qualcomm's stock traded higher overnight, closing at $184.87 on October 2. Huawei expects the deal to boost its licensing revenue above $6.9 billion. Separately, Qualcomm is suing Arm Holdings over royalty payments.

PTC (PTC) shares rose after Schneider Electric agreed to acquire it for $22.6 billion in cash. Qualcomm (QCOM) shares increased following a patent licensing deal with Huawei. Taiwan Semiconductor (TSM) shares gained on potential collaboration talks with Elon Musk's Terafab.

Qualcomm is suing Arm Holdings, alleging breach of contract and damages from a 2024 termination threat disclosure. Arm denies allegations and argues Qualcomm should not recover damages. A jury trial is underway, with a separate bench trial on good faith negotiations. The licensing agreement is valid until 2033. Qualcomm has not recorded potential losses from the matter.